Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy

SIMPLE SUMMARY: Though patients with sensitizing epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer have been known to have rapid and durable responses to tyrosine kinase inhibitors, a subset of patients have inferior outcomes and may benefit from therapy escalation. Neutroph...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Nicole K., Rouhani, Sherin J., Bestvina, Christine M., Ritz, Ethan M., Gilmore, Brendan A., Tarhoni, Imad, Borgia, Jeffrey A., Batus, Marta, Bonomi, Philip D., Fidler, Mary Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003851/
https://www.ncbi.nlm.nih.gov/pubmed/33804721
http://dx.doi.org/10.3390/cancers13061426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003851/
https://www.ncbi.nlm.nih.gov/pubmed/33804721
http://dx.doi.org/10.3390/cancers13061426

Ejemplares similares